James Rake
Impact in
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Toxicology top 5%
Papers in
-
- Cancer therapeutics and mechanisms 12
-
- Antibiotics Pharmacokinetics and Efficacy 4
- Microbial Natural Products and Biosynthesis 3
- Co-authors
- R. G. Eagon (5 shared papers)John M. Yarbrough (3 shared papers)Thomas H. Corbett (10 shared papers)Mark P. Wentland (10 shared papers)John J. Rowe (1 shared paper)Susan Pugh (3 shared papers)Douglas V. Faller (2 shared papers)Miguel A. Quiñones (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (4 papers)Journal of Medicinal Chemistry (3 papers)The Journal of Antibiotics (2 papers)Investigational New Drugs (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
James Rake
27 papers receiving 765 citations
Peers
Comparison fields: 5 of 101
- Pharmaceutical Science 120
- Toxicology 41
- Pollution 107
- Organic Chemistry 228
- Pharmacology 110
Countries citing papers authored by James Rake
This map shows the geographic impact of James Rake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Rake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Rake more than expected).
Fields of papers citing papers by James Rake
This network shows the impact of papers produced by James Rake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Rake. The network helps show where James Rake may publish in the future.
Co-authors
The 25 scholars most cited alongside James Rake, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 174 | |
| 2 | 1980 | 95 | |
| 3 | 1979 | 85 | |
| 4 | 1993 | 58 | |
| 5 | 1997 | 39 | |
| 6 | 1991 | 33 | |
| 7 | 1995 | 32 | |
| 8 | 1995 | 30 | |
| 9 | 1986 | 28 | |
| 10 | 1991 | 26 | |
| 11 | 1980 | 24 | |
| 12 | 1994 | 21 | |
| 13 | 1988 | 19 | |
| 14 | Pharmacokinetic studies in mice of two new thioxanthenones (183577 and 232759) that showed preferential solid tumor activity. | 1997 | 18 |
| 15 | 2001 | 17 | |
| 16 | 1974 | 17 | |
| 17 | Phase I pharmacokinetic study of the novel antitumor agent SR233377. | 2000 | 17 |
| 18 | 1999 | 16 | |
| 19 | 1998 | 15 | |
| 20 | 1990 | 14 |
About James Rake
James Rake is a scholar working on Molecular Biology, Pharmacology, Organic Chemistry, Oncology and Genetics, having authored 29 papers that have together received 828 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (12 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Cancer Treatment and Pharmacology (3 papers), Microbial Natural Products and Biosynthesis (3 papers), Bacterial Genetics and Biotechnology (3 papers), Synthesis and Biological Evaluation (3 papers), Synthesis and biological activity (3 papers) and Bioactive Compounds and Antitumor Agents (3 papers). The work is most often cited by research in Pharmaceutical Science (120 citations), Toxicology (41 citations), Pollution (107 citations), Organic Chemistry (228 citations) and Pharmacology (110 citations). James Rake has collaborated with scholars based in United States, France and Italy. Frequent co-authors include R. G. Eagon, John M. Yarbrough, Thomas H. Corbett, Mark P. Wentland, John J. Rowe, Susan Pugh, Douglas V. Faller, Miguel A. Quiñones, Susan Coughlin and Julie Jones. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, The Journal of Antibiotics, Investigational New Drugs and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.